10-Q: iAnthus Q3 2025: Strategic Divestitures Amidst Financial Strain

Sentiment:

Quarterly Report


iAnthus Capital Holdings reports a reduced net loss for Q3 2025, driven by strategic asset divestitures, but faces ongoing liquidity challenges and internal control weaknesses.

Delay expectedCash consideration payments for the Cheetah Acquisition are subject to performance benchmarks; if not met, payment dates will be delayed until benchmarks are achieved, with full cash consideration not delayed more than 24 months after closing.The Roberts lawsuit trial date was repeatedly vacated and rescheduled before a settlement was reached.The Maryland Cannabis Administration initially delayed consideration of the LMS ownership transfer request until the S8 Arbitration was complete.
Capital raiseThe company's ability to continue as a going concern is dependent upon its ability to raise additional capital.The company expects to finance upcoming capital plans through a combination of additional financings, divestitures, and cash flows from operations.The company may seek additional capital due to favorable market conditions and/or for strategic opportunities and initiatives.The Recapitalization Transaction involved the issuance of 6,072,579,705 common shares to Secured and Unsecured Lenders.The 2024 NJ Amendment fee of $1.6 million was satisfied through the issuance of common shares.
Worse than expectedThe working capital deficiency worsened significantly to $17.8 million as of September 30, 2025, from $0.7 million as of December 31, 2024.Operating cash flow for the nine months ended September 30, 2025, decreased substantially to $1.2 million from $10.7 million in the prior year.Total revenues for the nine months decreased to $108.7 million from $124.8 million year-over-year.The accumulated deficit deepened to $1,361.4 million from $1,335.3 million.Material weaknesses in internal controls over financial reporting were identified.

Summary

  • Net loss for the nine months ended September 30, 2025, was $26.1 million, an improvement from $35.4 million in the prior year.
  • Total revenues for the nine months decreased to $108.7 million from $124.8 million year-over-year, primarily due to divestitures in the Western region.
  • The Eastern region saw a revenue increase of 6.2% to $100.1 million, boosted by New Jersey's wholesale program expansion and the Cheetah Acquisition in Illinois and Pennsylvania.
  • The Western region's revenue significantly decreased by 71.9% to $8.6 million due to the deconsolidation of Nevada operations and the sale of Arizona assets.
  • Operating cash flow for the nine months decreased to $1.2 million from $10.7 million in the prior year.
  • The company completed the acquisition of LMS Wellness, Benefit LLC on April 21, 2025, after resolving legal disputes.
  • Strategic divestitures included Nevada assets for $5.9 million and Arizona assets for $36.5 million, generating significant cash proceeds and gains.
  • A $1.4 million loss was recognized from the sale of the AZ Note for $11.3 million.
  • The company settled the Roberts lawsuit for $5.5 million and the Canaccord claim for $2 million.
  • Material weaknesses in disclosure controls and internal control over financial reporting were identified, with a remediation plan underway.

Sentiment

Score: 3

Explanation: While the net loss decreased and strategic divestitures generated cash, the company faces significant financial challenges including a worsening working capital deficiency, substantially reduced operating cash flow, and an increasing accumulated deficit. The identified material weaknesses in internal controls and ongoing legal matters add to the negative sentiment, despite some positive regional revenue growth and successful acquisitions/divestitures. The 'going concern' warning is a major red flag.

Positives

  • Net loss for the nine months ended September 30, 2025, improved to $26.1 million from $35.4 million in the prior year.
  • Eastern region revenues increased by 5.9% for the three months and 6.2% for the nine months ended September 30, 2025, driven by New Jersey and new markets (Illinois and Pennsylvania).
  • Successful acquisition of LMS Wellness, Benefit LLC on April 21, 2025, after resolving legal disputes.
  • Strategic divestitures of Nevada assets for $5.9 million and Arizona assets for $36.5 million generated significant cash proceeds and gains on deconsolidation ($5.7 million for Nevada, $6.3 million for Arizona).
  • Investing activities generated positive cash flow of $9.9 million for the nine months ended September 30, 2025, compared to a net cash outflow of $2.8 million in the prior year, largely due to divestiture proceeds.
  • Deferred Professional Fees owed to related parties were reduced by a $5.0 million cash payment and $1.0 million forgiveness, with the outstanding balance decreasing from $9.2 million to $2.2 million.

Negatives

  • Total revenues decreased to $108.7 million for the nine months ended September 30, 2025, from $124.8 million in the prior year.
  • Gross profit decreased to $50.6 million for the nine months ended September 30, 2025, from $56.0 million in the prior year.
  • Operating cash flow significantly decreased to $1.2 million for the nine months ended September 30, 2025, from $10.7 million in the prior year.
  • Working capital deficiency worsened to $17.8 million as of September 30, 2025, from $0.7 million as of December 31, 2024.
  • Accumulated deficit deepened to $1,361.4 million as of September 30, 2025, from $1,335.3 million as of December 31, 2024.
  • A $1.4 million loss was recognized on the sale of the AZ Note.
  • Credit loss provisions of $1.8 million were recorded for the Massachusetts promissory notes due to non-receipt of scheduled payments.
  • Harvested plant material in the Eastern region decreased by 15.4% for the nine months ended September 30, 2025, due to Hurricane Milton impact and harvest timing.
  • Significant cash used in financing activities, $12.2 million, primarily for debt repayments.

Risks

  • Substantial doubt exists regarding the company's ability to continue as a going concern for at least 12 months due to substantial losses and a working capital deficiency.
  • The company's business activities, though legal under state laws, remain illegal under U.S. federal law, posing a material adverse effect risk.
  • Inability to secure additional capital when needed and on favorable terms, or at all, could negatively impact financial condition and force curtailment or cessation of operations.
  • Outstanding debt instruments impose restrictions on operating and financing activities, including incurring additional indebtedness, granting liens, making dividends, issuing shares, and selling assets.
  • Ongoing lawsuits and claims, such as the Walmer matter, could result in material adverse judgments or settlements.
  • Material weaknesses in disclosure controls and internal control over financial reporting (reviewing Service Organization Control Reports, effective risk assessment/monitoring) could adversely affect the ability to record, process, summarize, and report financial data.
  • Continued competitive pressures in markets like Florida leading to price compression and lower sales volume.
  • Impact of natural disasters, such as Hurricane Milton, on cultivation output.

Future Outlook

Management expects total operating expenses to remain consistent over the remainder of 2025, maintaining a disciplined capital allocation approach and closely monitoring expenditures. The company anticipates continuing to generate positive cash flows from operations in the near future, despite the substantial losses and working capital deficiency. However, there is no assurance of continued positive cash flows. The company plans to redirect resources from divestments to growth initiatives in Florida, Maryland, New Jersey, Massachusetts, and New York, while maintaining a retail presence in Arizona.

Management Comments

  • "We believe it may continue to generate positive cash flows from operations in the near future, notwithstanding the foregoing, the substantial losses and working capital deficiency cast substantial doubt on the Companys ability to continue as a going concern for a period of no less than 12 months from the date of this report."
  • "We have taken the necessary measures to control our discretionary spending and employ capital as efficiently as possible."
  • "After normalizing for one-time items, we expect total operating expenses to remain consistent over the remainder of 2025 as we continue to employ a disciplined capital allocation approach and continue to closely monitor operating expenditures and discretionary spending."
  • "As we continue to expand our operations and as these operations become more established, we continue to expect cash flow to be provided from operations, and we intend to place less reliance on financing from other sources to fund our operations."

Industry Context

The company operates in the U.S. cannabis industry, which faces the unique challenge of being legal at the state level but illegal under federal law. This federal illegality impacts financial operations (e.g., IRC Section 280E) and access to traditional capital. The company's strategy of divesting non-core assets and focusing on key growth markets (Florida, Maryland, New Jersey, Massachusetts, New York) aligns with a trend of consolidation and market optimization seen in the maturing cannabis industry, where companies seek to strengthen balance sheets and achieve profitability in core regions. The competitive pressures mentioned in Florida, leading to price compression, indicate a challenging market environment.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Board Member, Audit Committee, Nominating and Corporate Governance CommitteeJohn Paterson2024-03-09Resignation; vacancy not yet filled by Consenting Unsecured Lenders.
Chief Executive Officer and Board MemberRichard ProudAppointment, unanimously approved by Investors.
Interim Chief Executive Officer, President, and DirectorRandy MaslowFormer officer, no longer in role.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe Investor Rights Agreement (IRA) outlines the rights of investors to designate nominees for election or appointment to the Board based on their Debt Exchange Common Share Percentage. Vacancies created by resignations of Consenting Unsecured Lenders' nominees have not been filled.2022-06-24Ensures investor representation on the board, but unfilled vacancies may impact board effectiveness or diversity of perspectives.
Executive AppointmentThe company is required to hire a Chief Executive Officer (and any successor thereto) who has been unanimously approved by the Investors and appoint them to the Board.Provides investors with significant influence over executive leadership and board composition.
Internal ControlsMaterial weaknesses were identified in disclosure controls and internal control over financial reporting, specifically regarding reviewing Service Organization Control Reports for key third-party service providers and performing effective risk assessment and/or monitoring internal controls over financial reporting.2025-09-30Adversely affects the company's ability to record, process, summarize, and report financial data, requiring significant remediation efforts to ensure compliance and financial integrity.

Legal Proceedings

  • **Roberts Matter**: Settled on June 15, 2025, for a total of $5.5 million, payable in installments through January 5, 2029. The lawsuit involved claims for monetary damages of $22.0 million plus treble damages related to an acquisition.
  • **Walmer Matter**: Plaintiffs filed an Amended Notice of Civil Claim on June 4, 2025, seeking damages of $1,770,263.56 plus bonus and interest for unpaid debentures, $440,000 plus $150,000 for breach of a consultancy agreement, and $1,000,000 for breach of duty of good faith. The company filed its response and counterclaim on July 4, 2025.
  • **Claim by Former Financial Advisor (Canaccord)**: Settled on August 8, 2025, for $2.0 million, payable in installments ($300,000 by August 20, 2025, and $1.7 million in 24 equal monthly installments starting September 19, 2025). Canaccord had claimed $2.236 million for an alleged fee.
  • **Arvin Saloum Arbitration**: Saloum claims damages between $1.0 million and $10.0 million for unpaid consulting fees. The arbitration is stayed pending resolution of a Declaratory Judgment Complaint in Arizona Superior Court.
  • **CGX Arbitration / LMS Wellness**: CGX Life Sciences, Inc. successfully acquired 100% ownership of LMS Wellness, Benefit LLC on April 21, 2025, after a legal dispute and court order to enforce judgment. This matter is now resolved.
  • **Michael Weisser Petition**: Weisser's petition seeking to unwind the Recapitalization Transaction and replace the board was rendered moot by the company's actions and has not had a hearing date requested.

Related Party Transactions

  • As of September 30, 2025, $187.4 million of long-term debt and accrued liabilities are due to related parties (lenders from the Recapitalization Transaction who hold greater than 5% voting interests).
  • Deferred Professional Fees of $6.3 million were owed to certain New Secured Lenders. This balance was reduced by a $5.0 million cash payment and $1.0 million forgiveness, with $2.2 million outstanding as of September 30, 2025.
  • Interest payable of $0.1 million as of September 30, 2025, on Senior Secured Bridge Notes is due to related parties.

Stakeholder Impact

  • **Shareholders**: Dilution from past share issuances (Recapitalization Transaction, NJ Amendment, Cheetah Acquisition). Potential for further dilution if additional capital raises involve equity. The 'going concern' warning poses a significant risk to shareholder value.
  • **Lenders/Creditors**: Significant portion of debt is held by related parties. Settlements of legal claims (Roberts, Canaccord) involve cash payments, impacting liquidity.
  • **Employees**: Share-based compensation (RSUs) is part of incentive plans. Changes in management roles.
  • **Customers**: Continued operations in key markets (Florida, Maryland, New Jersey, Massachusetts, New York) and new brand (Cheetah) aim to serve customers. Divestitures in Nevada and Arizona impact customer access in those regions.
  • **Suppliers**: No specific impact mentioned, but general business operations and liquidity could affect supplier relationships.

Next Steps

  • Remediate identified material weaknesses in disclosure controls and internal control over financial reporting, including dedicating additional resources to ITGCs and developing a roadmap to become SOX compliant.
  • Continue to employ a disciplined capital allocation approach and closely monitor operating expenditures and discretionary spending.
  • Redirect resources obtained from divestments to growth initiatives in Florida, Maryland, New Jersey, Massachusetts, and New York.
  • Continue to work towards resolving the Walmer matter.
  • Make scheduled payments for the Roberts Settlement Agreement ($150,000 on January 5, 2026, then $4,100,000 in equal monthly installments over 36 months starting January 5, 2026).
  • Make scheduled payments for the Canaccord settlement ($1.7 million in 24 equal monthly installments, beginning on September 19, 2025).
  • Evaluate the impact of recently issued FASB ASUs (2024-03, 2025-01, 2025-05, 2025-06) on financial reporting practices.

Key Dates

DateDescription
2013-11-15iAnthus Capital Holdings, Inc. incorporated.
2017-12-08CGX Life Sciences, Inc. entered into option agreements to acquire LMS Wellness, Benefit LLC.
2018-01-01Acquisition of GrowHealthy Holdings, LLC assets (early 2018).
2019-02-01MPX Bioceutical Corporation acquisition (February 2019).
2019-05-29Walmer Capital Limited filed a statement of claim against MPX ULC.
2020-07-10Restructuring Support Agreement signed.
2020-08-06Roberts filed a lawsuit against Randy Maslow.
2021-08-19Arvin Saloum filed a Demand for Arbitration against The Healing Center Wellness Center, Inc. and iAnthus Arizona, LLC.
2021-11-22Company exercised option to acquire LMS.
2021-12-31Board approved Amended and Restated Omnibus Incentive Plan and RSU allocations.
2022-05-23CGX Life Sciences, Inc. filed a demand for arbitration against LMS Wellness, Benefit LLC and William Huber.
2022-06-20Michael Weisser commenced a petition against ICH and its former board of directors.
2022-06-24Recapitalization Transaction closed; June Secured Debentures and June Unsecured Debentures issued.
2023-04-05Canaccord Genuity Corp. filed a Statement of Claim against the Company.
2023-07-01LMS converted its medical-only license to a dual license.
2024-02-09Mayflower Medicinals Inc. entered into an Asset Purchase Agreement to sell Massachusetts assets.
2024-02-162024 NJ Amendment to Senior Secured Bridge Notes effective.
2024-02-23GreenMart of Nevada NLV, LLC entered into an Asset Purchase Agreement to sell Nevada assets and a Management Agreement.
2024-06-24Nevada Management Agreement Effective Date; Nevada operations deconsolidated.
2024-09-27Massachusetts asset sale closed.
2024-12-30Asset Purchase Agreement with Cheetah Enterprises, Inc. signed.
2025-01-01Company began estimating inventory value under standard costing.
2025-02-05Consent and release agreement with Secured Lenders regarding Deferred Professional Fees.
2025-02-06Definitive agreements for Arizona asset sale signed.
2025-02-10Effective closing date for Arizona asset sale.
2025-02-14Arizona asset sale closed.
2025-03-04Maryland Cannabis Administration approved transfer of LMS ownership to CGX.
2025-03-20Nevada Cannabis Compliance Board approved NV Purchase Agreement.
2025-03-31Effective closing date for Nevada asset sale.
2025-04-18Court granted CGX's Motion to Enforce Judgment against LMS and Huber.
2025-04-21LMS complied with court order, CGX now owns 100% of LMS.
2025-06-04Walmer plaintiffs filed an Amended Notice of Civil Claim.
2025-06-15Roberts Settlement Agreement executed.
2025-06-17Joint Stipulation to Dismiss Roberts matter with prejudice approved by court.
2025-06-26Hearing on Canaccord's Motion for Summary Judgment held.
2025-07-04Company and MPX ULC filed response and counterclaim in Walmer matter.
2025-08-08Canaccord settlement agreement executed.
2025-08-29Promissory Note Purchase Agreement for AZ Note sale closed.
2025-09-02Cash proceeds from AZ Note sale applied to Deferred Professional Fees.
2025-09-19First monthly installment payment due for Canaccord settlement.
2025-09-30End of quarterly period.
2025-11-11Number of common shares outstanding was 6,817,461,358.
2025-11-12Filing date of 10-Q.
2025-12-15Effective date for ASU 2025-05 (Financial Instruments Credit Losses).
2026-01-05First installment payment for Roberts Settlement Agreement.
2026-02-16Maturity date for Senior Secured Bridge Notes.
2026-04-01First earn-out payment due for Cheetah Acquisition.
2026-12-15Effective date for ASU 2024-03 (Income Statement Reporting Comprehensive Income) and ASU 2025-01 (Expense Disaggregation).
2027-06-24Maturity date for June Secured Debentures and June Unsecured Debentures.
2027-12-15Effective date for ASU 2024-03 (interim reporting periods) and ASU 2025-06 (Intangibles Goodwill and Other Internal-Use Software).
2028-04-01Final earn-out payment due for Cheetah Acquisition.
2028-07-01End of 5-year restriction on LMS license transfer.
2029-01-05End of Roberts Settlement Agreement monthly installments.

Recommendation

sell

The company faces severe financial distress, evidenced by a substantial working capital deficiency ($17.8 million), significantly reduced operating cash flow ($1.2 million for nine months), and a deepening accumulated deficit ($1.36 billion). The 'going concern' warning is a critical red flag, indicating significant uncertainty about the company's long-term viability. While strategic divestitures generated some cash and reduced the net loss, these are one-time events that do not address the underlying operational cash burn. The identified material weaknesses in internal controls further undermine confidence. The ongoing legal proceedings, even with some settlements, represent continued financial drain and operational distraction. Given the severe liquidity issues, the high debt burden, and the fundamental uncertainty about its ability to continue operations, the stock carries extreme risk.

Keywords

Cannabis, Multi-state operator, SEC filing, 10-Q, Financial results, Divestitures, Acquisitions, Liquidity, Going concern, Legal proceedings, Internal controls, Marijuana, Cultivation, Dispensary, Wholesale, Eastern Region, Western Region

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.